MEDP Medpace Holdings shares rise 435 percent after Q1 2026 EPS outpaces consensus analyst expectations Fidelity National Information Services TFC Deep Value Opportunity Emerges Ahead of Q1 Payments Sector Earnings Pfizer Inc PFE Strategic CDK Inhibitor Supply Partnership with Relay Therapeutics Validates Atirmociclib Commercial Potential in Metastatic Breast Cancer